Literature DB >> 9207383

Genetic evidence for mother-to-infant transmission of hepatitis G virus.

B Fischler1, C Lara, M Chen, A Sönnerborg, A Nemeth, M Sällberg.   

Abstract

Mother-to-infant transmission of hepatitis G virus (HGV [or GBV-C]) was studied in sera from 42 mothers at high risk for bloodborne infections and from their 45 infants (3 twin pairs). Seven (17%) of the mothers had HGV RNA in serum by a polymerase chain reaction assay. One of the 8 (12.5%) infants born to HGV-infected mothers became positive for HGV at 3 months of age. He remained HGV-infected throughout the study (42 months), with no signs of liver disease. His twin sister remained HGV-negative despite the presence of serum and salivary HGV in both the mother and the brother. Analysis of HGV sequences from the infected mother and the infected child confirmed a genetic link between the virus of the mother and the infected child. Thus, mother-to-infant transmission of HGV, presumably occurring at partus, may cause persistent HGV viremia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207383     DOI: 10.1086/517267

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products.

Authors:  R Halasz; L Barkholt; C Lara; C Hultgren; Y Ando; U Broomé; B Fischler; A Nemeth; B G Ericzon; A Sönnerborg; M Sällberg
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 2.  GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease.

Authors:  M Sathar; P Soni; D York
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

Review 3.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

4.  Prevalence of TT virus and GBV-C infections among patients with liver diseases and the general population in Shanghai, China.

Authors:  X Ding; M Mizokami; L Y Kang; K Cao; E Orito; Y Tanaka; R Ueda; M Sasaki
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

5.  Molecular evidence of mother-to-infant transmission of hepatitis G virus among women without known risk factors for parenteral infections.

Authors:  C Menéndez; J M Sánchez-Tapias; P L Alonso; M Giménez-Barcons; E Kahigwa; J J Aponte; H Mshinda; M M Navia; M T Jiménez de Anta; J Rodés; J C Saiz
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

6.  Prevalence of hepatitis G virus infection and homology of different viral strains in Southern China.

Authors:  Gang Li; Hui-Hui Ma; Geroge K K Lau; Yin-Kit Leung; Chun-Lan Yao; Yu-Tian Chong; Wen-Hui Tang; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

7.  Analysis of GB virus C markers in families over three generations.

Authors:  M Chen; B Fischler; C Hultgren; R Halasz; A Nemeth; M Sällberg
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia.

Authors:  I E Souza; J B Allen; J Xiang; D Klinzman; R Diaz; S Zhang; K Chaloner; D Zdunek; G Hess; C F Williams; L Benning; J T Stapleton
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

9.  Detection of hepatitis G virus RNA in persons with and without known risk factors for blood-borne viral infections in Sweden and Honduras.

Authors:  C Lara; R Halasz; A Sönnerborg; M Sällberg
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

10.  The prevalence of GB virus C/hepatitis G virus RNA among healthy and HCV-infected Catalan children.

Authors:  Gemma Claret; Antoni Noguera; Araceli González-Cuevas; Juan José García-García; Clàudia Fortuny; Carmen Muñoz-Almagro
Journal:  Eur J Pediatr       Date:  2007-10-27       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.